Litigation Details for Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc. (D. Del. 2015)
✉ Email this page to a colleague
Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc. (D. Del. 2015)
| Docket | ⤷ Try a Trial | Date Filed | 2015-11-05 |
| Court | District Court, D. Delaware | Date Terminated | 2016-05-23 |
| Cause | 35:271 Patent Infringement | Assigned To | Gregory Moneta Sleet |
| Jury Demand | None | Referred To | |
| Patents | 8,288,434; 8,663,699 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .
Details for Dow Pharmaceutical Sciences, Inc. v. Tolmar, Inc. (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2015-11-05 | 1 | United States Patent Nos. 8,288,434 (“the ’434 patent”) and 8,663,699 (“the ’699 patent”) arising under… THE PATENTS IN SUIT 8. The U.S. Patent and Trademark Office (“PTO…PTO”) issued the ’434 patent on October 16, 2012. The ’434 patent claims, inter alia, formulations of…. Dow is the assignee of the ’434 patent. A copy of the ’434 patent is attached hereto as Exhibit A. …. The PTO issued the ’699 patent on March 4, 2014. The ’699 patent claims, inter alia, methods of | External link to document | |
| 2015-11-05 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,288,434 B2; 8,663,699 B2. (… 2015 23 May 2016 1:15-cv-01030 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
